Linda D Bobo, Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 3314 Patriot Ct, Herrin, IL 62948 Phone: 618-999-3005 Fax: 618-993-0752 |
Sarah Altamimi, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3314 Patriot Ct, Herrin, IL 62948 Phone: 618-993-1591 Fax: 618-993-1595 |
Cora E. Musial, PHD,MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3314 Patriot Ct, Herrin, IL 62948 Phone: 618-993-0056 Fax: 618-993-0752 |
Abdelhameed Nawwar, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3314 Patriot Ct, Herrin, IL 62948 Phone: 618-993-1591 Fax: 618-993-1595 |
News Archive
The first HIV vaccine efficacy study to launch anywhere in seven years is now testing whether an experimental vaccine regimen safely prevents HIV infection among South African adults.
A team of researchers from Imperial College London has conducted a study aimed at calculating a reasonably accurate case fatality ratio and infection fatality ratio, which is based on Chinese data as well as international reports. The research is published on the pre-print server MedRxiv.
A new study by researchers at The Hebrew University of Jerusalem in Israel reports the discovery of a promising group of E channel inhibitors with significant antiviral activity. This could be developed into new treatment agents for this often-deadly virus.
The Huffington Post Investigative Fund: "As federal officials encourage the rapid expansion of electronic medical records to help doctors improve care and cut costs, they lack a reliable and systematic method for tracking the safety of these products, agency data and audits show. Instead, the Food and Drug Administration depends on a spotty warning system that can take a year to flag serious computer malfunctions and other software glitches.
Results of a new study by UCLA researchers has found that a groundbreaking new triple combination therapy shows promising signs of more effectively controlling advanced melanoma than previous BRAF + MEK inhibitor or BRAF inhibitor + immunotherapy combos alone, and with increased immune response and fewer side effects.
› Verified 2 days ago